Journal Home
Search for

Volume 131, Issue 3, Pages 280-287 (September 2004)


View previous. 17 of 42 View next.

A new measure of placebo response and patient satisfaction in office encounters

Presented at the Annual Meeting of the American Academy of Otolaryngologists–Head and Neck Surgery, Orlando, Fl, September 2003.

Alexander Ovchinsky, MDaCorresponding Author Informationemail address, Nadia Ovchinsky, MD, MBAb, Richard M. Rosenfeld, MD, MPHa

Abstract 

Objectives

Placebo response is defined as a change in health status resulting from the symbolic significance attributed by the patient or proxy to the physician encounter. Our goals were to validate the PR12 survey as a measure of placebo response and to analyze the placebo response as a discrete and measurable component of everyday office encounters with the otolaryngologist.

Study design

This was a prospective, before-and-after clinical outcomes study of 95 children aged 6 months to 12 years conducted in an academic metropolitan pediatric otolaryngology practice. Caregivers completed the PR-12 survey at entry and at least 4 weeks later. The survey included 3 domains (4 questions each) reflecting the main components of the placebo response: meaningful explanation, care and concern, and mastery and control. PR-12 was correlated with longitudinal change in health status at least 1 to 2 months after the baseline visit. Outcome measures included direct and indirect measures of change in disease-specific quality of life and satisfaction with change.

Results

Test-retest reliability was fair for most PR-12 survey items (R = 0.41 to 0.76) but was higher for domains (0.60 to 0.66) and the overall survey score (0.66). PR-12 had excellent internal consistency (Cronbach's alpha 0.91) and appropriate construct validity. Caregiver satisfaction change at follow-up correlated with the PR-12 (r = −.25, P = 0.036). Conversely, no correlation was seen between the PR-12 and direct and indirect measures of change in disease specific quality of life.

Conclusion

Placebo response is an important and potentially measurable aspect of clinical encounters. PR-12 is a promising first step at creating a brief, reliable, and valid instrument to assess the placebo response.

Significance

Reemphasizing the therapeutic potential of the doctor-patient relationship may improve quality of care and disease outcomes.

a Department of Otolaryngology, State University of New York Downstate Medical Cente and The Long Island College Hospital, Brooklyn, NY, , USA(Drs A. Ovchinsky and Rosenfeld)

b Department of Pediatrics, Columbia Presbyterian Medical Center, New York, NY , USA(Dr N Ovchinsky)

Corresponding Author InformationReprints requests: Alexander Ovchinsky, MD, Department of Otolaryngology, New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, USA

 Sponsored by an Outcomes Research Small Project Grant from the AAO-HNSF.

PII: S0194-5998(04)00194-9

doi:10.1016/j.otohns.2004.03.003


View previous. 17 of 42 View next.